CNS Pharmaceuticals, Inc. - Enterprise Value

The Enterprise Value as of June 2026 (TTM) for CNS Pharmaceuticals, Inc. (CNSP) is -17998.00

According to CNS Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -17998.00. This represents a change of -99.62% compared to the average of -4698637.37 of the last 4 quarters.

CNS Pharmaceuticals, Inc. (CNSP) Historical Enterprise Value (quarterly & annually)

How has CNSP Enterprise Value performed in the past?

The mean historical Enterprise Value of CNS Pharmaceuticals, Inc. over the last ten years is 25.31M. The current -17998.00 Enterprise Value has changed -107.11% with respect to the historical average. Over the past ten years (40 quarters), CNSP's Enterprise Value was at its highest in in the March 2019 quarter at 75.31M. The Enterprise Value was at its lowest in in the March 2025 quarter at -9128704.92.

CNS Pharmaceuticals, Inc. (CNSP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of CNS Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CNS Pharmaceuticals, Inc. (CNSP) Average Enterprise Value

How has CNSP Enterprise Value performed in the past?

The current Enterprise Value of CNS Pharmaceuticals, Inc. (CNSP) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

CNS Pharmaceuticals, Inc. (CNSP) Enterprise Value vs. Peers

How is CNSP’s Enterprise Value compared to its peers?

CNS Pharmaceuticals, Inc.’s Enterprise Value is less than Windtree Therapeutics, Inc. (13.40M), greater than Pasithea Therapeutics Corp. (-46679300.00), greater than NLS Pharmaceutics AG (-1582876.00), greater than Soligenix, Inc. (-1581247.00), greater than Oragenics, Inc. (-3572075.00), greater than 60 Degrees Pharmaceuticals, Inc. (-1863049.00), greater than Clearmind Medicine Inc. (-8201702.00), less than Ensysce Biosciences, Inc. (2.02M), greater than GRI Bio, Inc. (-10821116.00), less than Silo Pharma, Inc. (1.63M),

Build a custom stock screener for CNS Pharmaceuticals, Inc. (CNSP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CNS Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CNS Pharmaceuticals, Inc. (CNSP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CNS Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.